Virtu Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,071
Closed -$220K 1780
2025
Q2
$220K Sell
2,071
-7,291
-78% -$792K 0.01% 884
2025
Q1
$1.16M Buy
+9,362
New +$1.22M 0.06% 234
2024
Q2
Sell
-11,696
Closed -$1.41M 1590
2024
Q1
$1.41M Buy
11,696
+2,819
+32% +$345K 0.11% 158
2023
Q4
$1.09M Buy
8,877
+4,538
+105% +$566K 0.09% 186
2023
Q3
$562K Buy
+4,339
New +$578K 0.06% 306
2022
Q4
Sell
-8,306
Closed -$1.11M 1887
2022
Q3
$1.11M Buy
+8,306
New +$1.26M 0.1% 175
2022
Q2
Sell
-1,480
Closed -$230K 1811
2022
Q1
$230K Sell
1,480
-232
-14% -$33.7K 0.02% 710
2021
Q4
$218K Buy
+1,712
New +$225K 0.02% 798
2021
Q2
Sell
-3,318
Closed -$545K 1779
2021
Q1
$545K Buy
+3,318
New +$546K 0.04% 483
2019
Q1
Sell
-2,074
Closed -$257K 1636
2018
Q4
$257K Sell
2,074
-2,523
-55% -$374K 0.01% 793
2018
Q3
$773K Buy
+4,597
New +$791K 0.05% 419
2018
Q2
Sell
-3,097
Closed -$468K 2245
2018
Q1
$468K Sell
3,097
-99
-3% -$14.5K 0.03% 734
2017
Q4
$430K Sell
3,196
-760
-19% -$105K 0.02% 952
2017
Q3
$578K Buy
+3,956
New +$598K 0.03% 804

Other funds holding JAZZ

Virtu Financial's JAZZ Position: Q3 2025 in Review

Virtu Financial sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2025, closing a stake of 2,071 shares — an estimated $220K sold.

Virtu Financial first reported a position in JAZZ in Q3 2017 and held it in 14 quarters. The position peaked at $1.41M in Q1 2024. 503 funds tracked by Wall St. Rank hold JAZZ as of Q3 2025.

  • Virtu Financial reported no remaining Jazz Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Virtu Financial sold 2,071 Jazz Pharmaceuticals shares in Q3 2025, an estimated $220K.
  • Virtu Financial first reported a position in Jazz Pharmaceuticals in Q3 2017 and held it in 14 quarters.
  • Virtu Financial's Jazz Pharmaceuticals position peaked at $1.41M in Q1 2024.
  • 503 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2025.

Based on Virtu Financial's 13F filing for Q3 2025, filed 14 Nov 2025.